Bright Future for The TJX Companies (TJX): Ross Stores, Inc. (ROST), Stein Mart, Inc. (SMRT)

Page 1 of 2

During a Wednesday earnings call, The TJX Companies, Inc. (NYSE:TJX) President/Chief Executive Officer Carol Meyrowitz said she’s repeatedly asked one question that I find myself positing quite a bit where the company is concerned: how can its positive operational momentum continue? When it sports a 21% five-year CAGR in EPS and steady annual gains in both sales (8.48% three-year CAGR) and operating income (16.25% three-year CAGR)—and given pundits’ ongoing worries about consumer discretionary spending in light of the Federal payroll tax increase, delayed income tax refunds, and nasty weather—the question’s popularity comes as little surprise.

Funny thing, though. Even as The TJX Companies, Inc. (NYSE:TJX) missed consensus estimates for fiscal 2014 EPS ($2.66-$2.78/share vs. $2.84) and sales ($26.8-$27.1 billion vs. $27.32)—equating to YOY growth of 7.7%-12.6% in the former metric based on a 52-week comparison and a rise of 3.5%-4.6% in the latter—shares appreciated. Following are a few likely reasons that TJX’s adherents aren’t fleeing despite the company’s slowing growth:

The TJX Companies, Inc. (NYSE:TJX)

TJX sits in a retail sweet spot along with Ross Stores, Inc. (NASDAQ:ROST) and Stein Mart, Inc. (NASDAQ:SMRT) by offering sought-after clothing and home furnishing brands at discount prices. This operational thrust worked exceedingly well (at least for The TJX Companies, Inc. (NYSE:TJX) and Ross) during the economic volatility of the past five years and should continue in earnest as many consumers remain cash strapped and the housing market continues its recovery, meaning value-based home goods are at a premium. Indeed, I’ve long marveled at Ross Stores’ operational prowess that includes continuous annual growth in key metrics such as sales and gross and operating margins.  Through December 31 Ross Stores, Inc. (NASDAQ:ROST) delivered a 10.2% five-year CAGR in sales– sales were $9.72 billion in 2012 and $5.98 billion in 2007–and gross and operating margins have expanded every year over the same period. Stein Mart, Inc. (NASDAQ:SMRT) recently emerged from a lackluster early 2012 by announcing January overall and same-store sales growth of 31.3% and 4.6%, respectively, and comparative 4Q gains of 11.3% and 6%. Plus, the company’s February comps came in at +0.6%, ahead of consensus estimates of flat growth. In all, Stein Mart has now achieved eight consecutive quarters of same-store sales growth. Beware, however, that Stein Mart must regain compliance with NASDAQ listing standards requiring timely filings of periodic reports with the Securities and Exchange Commission. No doubt it’s impossible to like the triumvirate equally–in my eyes Stein Mart, Inc. (NASDAQ:SMRT) isn’t quite in the same league as TJX or Ross Stores, Inc. (NASDAQ:ROST)–but it’s easy to like the consumer value proposition they each offer.

Meyrowitz said during the Wednesday call that the company plans conservatively and aims to beat future estimates. Last year, for example, The TJX Companies, Inc. (NYSE:TJX) forecasted 0-2% growth in same-store sales and came in at +7%. I’m not saying such a positive surprise will repeat itself this year, but I’ve always been a big fan of a company’s goal and ability to under promise and over deliver.

TJX said February same-store sales will likely be flat compared to +8% a year ago, certainly a disappointing admission. Yet the month ended up 1% after the company said sales picked up as March approached. Also important: Meyrowitz allayed, at least for the time being, any concerns over weakness in consumer discretionary spending by asserting that the comparative February underperformance was “absolutely a weather story for us,” adding that comps have been negative in the snow-covered northeast but positive in the sun-soaked southeast. Translation: Mother Nature can be fickle, to be sure, but the company hasn’t witnessed any meaningful hit to consumer health.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!